Author:
Li Wen,Peng Xinhao,Lang Jinyi,Xu Chuan
Funder
National Natural Science Foundation of China
Subject
Pharmacology (medical),Pharmacology
Reference201 articles.
1. A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors;Abdul;Invest. New Drugs,2019
2. Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[ cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development;Aguilar;J. Med. Chem.,2017
3. Causes of genome instability;Aguilera;Annu. Rev. Genet.,2013
4. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair;Alt;J. Biol. Chem.,2005
5. Post-translational modifications and activation of p53 by genotoxic stresses;Appella;Eur. J. Biochem.,2001
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献